Clinical Trials Browser

Locally Advanced Rectal Cancer With Liver Metastases

Neoplasms, Neuroendocrine Tumors

Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Rectal Neoplasms

Triple Negative Breast Neoplasms

Stomach Neoplasms

Acrocephalosyndactylia

Primary/Secondary Prevention

Urinary Bladder Neoplasms

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Carcinoma, Non-Small-Cell Lung

Neoplasms, Germ Cell and Embryonal

Brain Neoplasms

Carcinoma, Non-Small-Cell Lung

Unresectable Non-small Cell Lung Cancer

Neoplasms, Ovarian Neoplasms

HR+/HER2- Breast Cancer

Pathologic Complete Response, Breast Neoplasms

Unresectable Pancreatic Cancer

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Papillomavirus Infections

Uterine Cervical Neoplasms, Renal Insufficiency

Colorectal Neoplasms

Stomatitis, Ulcer

Pathologic Complete Response, Breast Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms

Gastric/Gastroesophageal Junction Adenocarcinoma

Cholangiocarcinoma

Pathologic Complete Response, Breast Neoplasms

Turcot syndrome, Endometrial Neoplasms

HER2 Low Breast Carcinoma

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Advanced Breast Cancer

Carcinoma, Hepatocellular

Breast Cancer Recurrent

Cervical Cancer Recurrent

Uterine Cervical Neoplasms

Chemotherapy

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Brain Neoplasms, Memory Disorders, Radiation Injuries, Cognitive Dysfunction

Colorectal Neoplasms

Clinical Trials

SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases

TENET

NEOPRIME

QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast Cancer

NOGA

SCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC

Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC

Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions

NCCH2006/MK010 Trial (FORTUNE Trial)

Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN

IMGeS

KOV-02S

TARGET-01

LART

DACT-GCT

Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases

Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC

Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.

OC-POP-PT

Serplulimab Combined With Chemotherapy for Early-stage HR+/HER2- Breast Cancer

SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

Dulastin

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease

AHTCRR-1

Copaíba-based Mouthwash in Oral Mucotitis Prevention and Treatment in Oral Cancer Patients During Radioteraphy

Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC

ACCESS-I

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer

Photo-medicine-Guided Dual Approach for Reoperation of Sentinel Lymph Nodes in Locally Recurrent Breast Cancer Patients

A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG

Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic Cholangiocarcinoma

Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer

SATELLITE

A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer

Study of SHR-A1811 in HER2-expression Advanced Breast Cancer with Brain Metastases

Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer

A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC

Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial

Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab

Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer

Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical Cancer

Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer

Toripalimab Plus FLOT in Locally Advanced Gastric Cancer

L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC

Digital Health Intervention to Improve Health Care and Outcomes for Breast Cancer Patients

LiBRA

ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC